Adeona Pharmaceuticals, a pharmaceutical company developing new medicines for serious central nervous systems diseases, has appointed Julie Caudill vice president of finance and corporate controller. Caudill brings to Adeona more than 15 years of biotechnology-related accounting and Securities and Exchange Commission compliance experience.

For the past 15 years, Caudill served in a variety of financial reporting positions at biotech company, Aastrom Biosciences, where she most recently served as corporate controller and corporate secretary. Caudill has experience in financial reporting, internal and external audit management, budget planning and control, treasury operations, and stock option reporting. Prior to Aastrom, Caudill served as accounting manager at KMS Industries, and senior accountant at Gelman Sciences.